1. Positron emission tomography (PET) with radiolabeled F(ab')2-trastuzumab fragments in patients (pts) with HER2-positive metastatic breast cancer (MBC): initial feasibility results;Akhurst;Breast Cancer Symposium,2008
2. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex;Ali;Nature,2006
3. Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress;Arlander;The Journal of Biological Chemistry,2003
4. Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33;Azoitei;The Journal of Experimental Medicine,2012
5. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents;Bagatell;Clinical Cancer Research,2000